Prospective Assessment of Fatigue and Health Status in Greek Patients With Breast Cancer Undergoing Adjuvant Radiotherapy

Abstract

Findings contribute to the growing body of evidence regarding fatigue and its impact on health status in Greek patients with breast cancer and provide insights for effective nursing assessment, patient education, and symptom management.

Fatigue in Gynecological Cancer Patients During and After Anticancer Treatment

“…In this longitudinal survey demographic variables and factors associated with the tumour and anti-cancer treatment were unrelated to the fatigue. A large body of evidence exists to support the finding that CRF during anti-cancer treatment is not associated with tumour stage (12,22,23,46,51,56,60,(68)(69)(70) or any demographic (12,22,23,34,49,55,56,60,62,64,(66)(67)(68)(69)(70)(71) or treatment-related variables (12,22,23,46,51,53,55,60,64,(68)(69)(70)(71)(72). In contrast, two studies have reported that females experience more fatigue then males (62,73), three have demonstrated an association between increasing age and lower fatigue (12,34,53), one between marital status and fatigue, with divorced women experiencing the most fatigue …”

Fatigue in Brazilian cancer patients, caregivers, and nursing students: a psychometric validation study of the Piper Fatigue Scale-Revised

“…The most frequent primary tumor sites were breast and colorectal. 11.0 (9.1); 9.0 (0-53) 8.6 (7.6); 6.13 (0-34) 10 …”

“…It has been validated in French [5], Dutch [4], Swedish [15], Greek [10], and Chinese [18] languages. The PFS-R was evaluated psychometrically in a cross-sectional study of women with breast cancer [16] following the development of the original PFS [17].…”

Fadiga clinicamente relevante em mulheres com câncer de mama: prevalência e fatores associados

“…Outros estudos sobre o tema têm adotado o mesmo ponto de corte, o que facilita comparações (4,(15)(16)(17)(18).…”

“…Durante a radioterapia, apenas 13% das pacientes referiram fadiga (15) e, em pacientes que realizaram terapia hormonal (4) o resultado foi semelhante (15,2%). Em pacientes antes do início de quimioterapia adjuvante, a prevalência de fadiga foi de 28% (16), mas em pacientes livres do câncer de mama, fadiga esteve presente em 41% (17) e 66,1% das amostras (18).…”